Chapter 15 — Chemistry In Everyday Life

Fig 1 — Educational Diagram: Introduction

Chemistry in Everyday Life studies how chemical substances and reactions affect daily activities — health (drugs and medicines), hygiene (soaps, detergents, disinfectants), nutrition (food additives, preservatives), materials (polymers, fibres) and environment. The chapter introduces basic concepts of medicinal and consumer chemistry at a level useful for understanding how chemicals are designed, how they act in the body and how they are used safely.

Medicinal chemistry — basic ideas

• Drug / Medicine: A chemical substance used to prevent, diagnose, relieve or cure a disease or to modify physiological functions.
• Chemotherapeutic agent: Any chemical used to treat disease; commonly used for drugs that act against microbes or cancer.
• Antibiotics: Substances produced by microorganisms (or synthetically prepared) that kill/inhibit other microorganisms (e.g., penicillin).
• Antiseptics vs Disinfectants: Antiseptics are safe for application on living tissues to prevent infection; disinfectants are used on inanimate surfaces to kill microbes (e.g., phenol for antisepsis, sodium hypochlorite as disinfectant).

Pharmacology basics (how drugs act and behave)

• Pharmacodynamics: What the drug does to the body — mechanism of action, receptor binding (agonist vs antagonist), efficacy and potency.
• Pharmacokinetics (ADME): Absorption, Distribution, Metabolism and Excretion — what the body does to the drug. These determine onset, intensity and duration of drug action.
• Key terms: Bioavailability (fraction reaching systemic circulation), half-life (time for concentration to halve), therapeutic window (range between effective and toxic doses), side effects, tolerance and dependence.

Why chemistry matters in daily life

• Design and safe use of medicines that cure or relieve illness.
• Formulation of household products (soaps, detergents, disinfectants) for hygiene and sanitation.
• Polymers/ fibres (nylon, polyester) and plastics used in clothing, packaging and appliances.
• Food additives and preservatives that extend shelf life and ensure safety.

Safety and societal issues

• Misuse of antibiotics leads to antimicrobial resistance — a major public-health concern.
• Side effects, drug interactions and environmental persistence of synthetic chemicals require informed use and regulation.

This introduction sets the stage for studying specific classes of drugs (antibiotics, analgesics, antipyretics, antiseptics), household chemicals (soaps, detergents, disinfectants) and polymers later in the chapter.

Fig 2 — Educational Diagram: Drugs and their Classification

Definition: Drugs are chemical substances used to prevent, diagnose, treat or cure diseases and to relieve symptoms. In chemistry context they interact with biological molecules to modify biochemical processes.

Broad classification (by source):

• Natural drugs: directly obtained from plants or microbes (e.g., morphine from opium, penicillin from Penicillium).
• Semi-synthetic drugs: chemically modified natural products (e.g., ampicillin from penicillin).
• Synthetic drugs: prepared entirely by chemical synthesis (e.g., aspirin, paracetamol, sulfa drugs).

Classification by biological effect / therapeutic action:

• Analgesics and antipyretics: relieve pain and reduce fever (aspirin, paracetamol).
• Antibiotics / antimicrobials: inhibit or kill microorganisms (penicillins, tetracyclines, ciprofloxacin).
• Antiseptics and disinfectants: kill or inhibit microbes on living tissues or surfaces (phenol, chloroxylenol, sodium hypochlorite).
• Tranquilizers / sedatives and hypnotics: depress the CNS to reduce anxiety or induce sleep (diazepam, barbiturates).
• Stimulants: increase activity in the CNS (caffeine, amphetamines).
• Narcotics / opioid analgesics: strong pain relief with potential for dependence (morphine, codeine).
• Hallucinogens: alter perception and cognition (LSD, THC from cannabis).
• Antacids: neutralize stomach acid (Mg(OH)2, Al(OH)3).
• Anticancer drugs: cytotoxic agents and targeted drugs (cyclophosphamide, methotrexate).
• Hormonal drugs and contraceptives: steroid hormones and analogues (ethinylestradiol, levonorgestrel).

Classification by chemical nature (important classes):

• Alkaloids (nitrogenous plant bases): morphine, quinine.
• Sulfonamides (sulfa drugs): para-aminobenzenesulfonamide (early antibacterial agents).
• Beta-lactams (penicillins and cephalosporins): inhibit bacterial cell wall synthesis.
• Macrolides, tetracyclines, aminoglycosides: inhibit bacterial protein synthesis (different ribosomal targets).
• Quinolones/fluoroquinolones: inhibit DNA gyrase/topoisomerase (ciprofloxacin).

Mode of action (general concepts):

• Drug-receptor interaction: drugs bind specific biomolecular targets (receptors, enzymes) like a key in a lock; binding alters biological function (agonist or antagonist effect).
• Enzyme inhibition: many drugs are enzyme inhibitors (e.g., penicillin inhibits transpeptidase to block peptidoglycan cross-linking in bacteria).
• Antimetabolites: mimic normal substrates and block metabolic pathways (methotrexate inhibits folate metabolism).

Pharmacokinetics (ADME) — factors determining drug action:

• Absorption, Distribution, Metabolism (usually in liver), Excretion (urine/feces) — these control onset, intensity and duration of action.
• Dose-response relationship: therapeutic window between minimum effective concentration and toxic concentration.

Antibiotic resistance and safety:

• Misuse and overuse of antibiotics lead to resistance (mechanisms include drug inactivation, target modification, efflux pumps, reduced uptake).
• Adverse effects and drug interactions: toxicity, allergic reactions (e.g., penicillin allergy), teratogenicity, dependence (narcotics).
• Importance of correct dose, duration and use of combination therapy to reduce resistance.

Desirable properties of an ideal drug: specific action, minimum side effects, stable, chemically pure, affordable, and easily administered.

Summary: Understanding drugs in chemistry covers their source, chemical class, mechanisms of action, therapeutic uses and risks. Chemical structure determines target interactions and pharmacological profile; correct use reduces resistance and adverse outcomes.

Fig 3 — Educational Diagram: Analgesics, Antipyretics and Anti-inflammatory Drugs

Definitions

Analgesics relieve pain without loss of consciousness. Antipyretics reduce fever by acting on the hypothalamic thermoregulatory centre. Anti-inflammatory drugs reduce inflammation (redness, swelling, pain, heat) by inhibiting biochemical mediators of inflammation.

Classes and mechanisms (concise)

• NSAIDs (Non-steroidal anti-inflammatory drugs): e.g. aspirin, ibuprofen, naproxen, diclofenac. They inhibit cyclooxygenase enzymes (COX-1 and COX-2) responsible for converting arachidonic acid to prostaglandins. Reduced prostaglandins → analgesic, antipyretic and anti-inflammatory effects. COX-1 inhibition causes common side effects (gastric irritation, platelet effects); COX-2 selective inhibitors (coxibs) give fewer GI effects but can have cardiovascular risks.
• Paracetamol (acetaminophen): primarily a central analgesic and antipyretic; it inhibits prostaglandin synthesis in the CNS more than in peripheral tissues, so it has weak peripheral anti-inflammatory activity. Overdose → hepatotoxicity.
• Opioid analgesics: e.g. morphine, codeine. Act on opioid receptors (mu, kappa, delta) in CNS to block pain transmission and perception. Effective analgesics but not primary antipyretics or anti-inflammatories; associated with sedation, respiratory depression, dependence.
• Steroidal anti-inflammatory drugs (glucocorticoids): e.g. prednisone. They act at the genomic level to induce lipocortin (annexin), which inhibits phospholipase A2 and reduces formation of arachidonic acid — broad and potent anti-inflammatory action but many systemic side effects with long-term use (immunosuppression, Cushingoid effects, osteoporosis).

Key biochemical pathway (concept)

Cell membrane phospholipids --(phospholipase A2)--> arachidonic acid --(COX)--> prostaglandins & thromboxanes. NSAIDs block COX; steroids block phospholipase A2 induction.

Important clinical/real-life points

• Aspirin (low dose) has antiplatelet effect and is used to reduce risk of thrombosis.
• Paracetamol is preferred for fever in children (avoid aspirin in viral infections because of Reye's syndrome).
• NSAIDs can cause gastric ulcers and renal impairment in susceptible people.
• Drug choice depends on balance of desired effects (pain relief, anti-inflammatory action) and side-effect profile.

Safety notes

Use drugs as directed. Overdose or prolonged use can cause serious adverse effects (liver damage with paracetamol; GI bleeding with NSAIDs; dependence and respiratory depression with opioids). This summary is educational, not medical advice.

Fig 4 — Educational Diagram: Antiseptics and Disinfectants

Introduction

Antiseptics and disinfectants are chemical agents used to destroy or inhibit microorganisms. Both reduce microbial load but differ in their area of application: antiseptics are applied to living tissues (skin, wounds), while disinfectants are used on inanimate surfaces and instruments.

Definitions and Key Differences

• Antiseptics: Chemical agents that can be safely applied to living tissues to inhibit or kill microbes (example: povidone–iodine, alcohols, chlorhexidine).
• Disinfectants: Stronger chemical agents usually unsuitable for living tissues; used to disinfect floors, instruments, water (example: sodium hypochlorite, phenolic compounds, formaldehyde).
• Bacteriostatic vs Bactericidal: Bacteriostatic agents inhibit growth; bactericidal agents kill microorganisms.

Classification (by chemical nature)

• Alcohols (ethanol, isopropanol): denature proteins and disrupt membranes; rapid action; effective at 60–90% (70% commonly used).
• Halogen-releasing agents (chlorine, hypochlorites, iodine, iodophores): oxidize cellular components and iodinate proteins; broad spectrum.
• Phenols and cresols (phenol, chloroxylenol/Dettol): disrupt cell membranes and denature proteins.
• Oxidizing agents (hydrogen peroxide, peracetic acid): produce free radicals/oxidize cell constituents.
• Aldehydes (formaldehyde, glutaraldehyde): alkylate proteins and nucleic acids; used for instrument sterilization.
• Quaternary ammonium compounds (QACs) (benzalkonium chloride): disrupt membranes; used as surface disinfectants and in some antiseptic formulations.
• Biguanides (chlorhexidine): disrupt cell membranes; used as antiseptic in mouthwashes and skin cleansers.

Mechanisms of Action

• Protein denaturation (alcohols, phenols, aldehydes) — enzymes and structural proteins lose function.
• Membrane disruption (alcohols, QACs, phenols) — loss of selective permeability.
• Oxidation (chlorine, hydrogen peroxide) — damage to proteins, lipids and nucleic acids by reactive oxygen species.
• Halogenation/iodination (iodine, hypochlorous acid) — modification of amino acids and enzymes.
• Alkylation (aldehydes) — covalent modification of biomolecules.

Factors Affecting Efficiency

• Concentration: Many agents show an optimum concentration (e.g., 60–90% ethanol). Too dilute or too concentrated may reduce effectiveness.
• Contact time: Longer exposure increases kill rate.
• Presence of organic matter: Blood, soil, or proteins can inactivate some disinfectants (notably halogens and aldehydes).
• pH and temperature: Can alter activity and stability.
• Type of microorganism: Spores and some non-enveloped viruses are more resistant than vegetative bacteria.

Common Uses and Safety

• Hand sanitizers: 60–80% ethanol or isopropanol (antiseptic)
• Surface disinfection: 0.1% sodium hypochlorite for routine disinfection, 1% or higher for blood spills (follow local guidelines)
• Wound antisepsis: povidone–iodine, chlorhexidine (with appropriate dilution)
• Instrument sterilization: glutaraldehyde or formaldehyde for heat-sensitive instruments

Safety note: Many disinfectants are corrosive, toxic, or irritant. Use recommended dilutions, avoid mixing chemicals (e.g., bleach + ammonia produces toxic chloramines), and follow label instructions and PPE guidance.

Resistance and Environmental Concerns

Overuse or incorrect use can select for tolerant organisms and cause environmental contamination. Proper concentrations, contact times, and rotation of disinfectants are recommended in clinical settings.

Summary

Antiseptics and disinfectants are essential to infection control. Choice depends on application (living tissue vs surfaces), spectrum required, and safety. Key factors—concentration, contact time, organic load, and target microbes—determine effectiveness.

Fig 5 — Educational Diagram: Chemotherapeutic Agents

Definition and scope
Chemotherapeutic agents are chemical substances used to prevent, control or cure diseases by killing or inhibiting the growth of pathogenic organisms (antimicrobials) or abnormal host cells (anticancer agents). The term was coined in the era of Paul Ehrlich, who introduced the idea of a 'magic bullet' that selectively targets disease-causing agents.

Classification (broad)

• Antibacterials (antibiotics and synthetic antibacterials): penicillins, cephalosporins, tetracyclines, aminoglycosides, macrolides, sulfonamides, quinolones.
• Antifungals: azoles (econazole), polyenes (amphotericin B).
• Antivirals: acyclovir, oseltamivir.
• Antiparasitics/antimalarials: quinine, chloroquine, artemisinin derivatives.
• Antineoplastic (anticancer) chemotherapeutics: alkylating agents (cyclophosphamide), antimetabolites (methotrexate), platinum complexes (cisplatin), plant alkaloids (vincristine).

Principles of selective toxicity
Effective chemotherapeutic agents exploit differences between the pathogen (or cancer cell) and the host. Selectivity is quantified by the therapeutic index (TI):

Therapeutic index (TI) = TD50 / ED50
(TD50 = dose producing toxic effect in 50% animals; ED50 = dose producing desired effect in 50%). Higher TI = safer drug.

Major modes of action

• Inhibition of cell wall synthesis: Beta-lactam antibiotics (penicillins, cephalosporins) block transpeptidase (penicillin-binding proteins), preventing peptidoglycan cross-linking → bactericidal.
• Inhibition of protein synthesis: Aminoglycosides (streptomycin) cause misreading of mRNA at 30S; tetracyclines block attachment of tRNA at 30S; chloramphenicol inhibits peptidyl transferase at 50S.
• Inhibition of nucleic acid synthesis: Quinolones inhibit DNA gyrase/topoisomerase; rifampicin inhibits RNA polymerase.
• Metabolic antagonists: Sulfonamides are PABA analogs that inhibit dihydropteroate synthase → block folic acid synthesis and hence nucleotide formation.
• Membrane disruption: Polymyxins interact with bacterial membranes causing permeability changes.
• DNA cross-linking and antimetabolites in cancer therapy: Alkylating agents (e.g., cyclophosphamide, cisplatin) cross-link DNA; antimetabolites (e.g., methotrexate) inhibit enzymes (dihydrofolate reductase) needed for DNA synthesis.

Resistance mechanisms

• Enzymatic drug inactivation (e.g., beta-lactamases hydrolyze penicillins).
• Target modification (e.g., altered penicillin-binding proteins, methylation of rRNA).
• Decreased drug uptake or increased efflux (efflux pumps).
• Bypass metabolic pathways (e.g., alternative folate sources).

Adverse effects and precautions
Chemotherapeutic agents can have side effects due to imperfect selectivity — allergic reactions (penicillin), nephrotoxicity (aminoglycosides), bone marrow suppression (chloramphenicol), teratogenicity, etc. Important principles: appropriate dosing, full course of therapy to reduce resistance, combination therapy where required, and monitoring therapeutic index.

Practical and societal points
Antibiotics revolutionized medicine but overuse/misuse in humans and animals has driven antimicrobial resistance (AMR), a major global health threat. Vaccination, hygiene, and stewardship programs complement chemotherapeutic use.

Summary
Chemotherapeutic agents are essential tools for treating infectious diseases and cancer. Understanding their mechanisms, selectivity (therapeutic index), resistance pathways, and safe use is central to clinical success.

Fig 6 — Educational Diagram: Antibiotics

Definition: Antibiotics are chemical substances produced by microorganisms or synthesized chemically that selectively kill or inhibit the growth of other microorganisms at low concentrations without harming the host. They are primarily used to treat bacterial infections.

Classification (by source):

• Natural antibiotics — produced by microbes (e.g., penicillin from Penicillium).
• Semi-synthetic — natural antibiotics chemically modified to improve properties (e.g., amoxicillin from penicillin core).
• Synthetic — fully prepared by chemical synthesis (e.g., sulfonamides, fluoroquinolones).

Classification (by action):

• Bactericidal: kill bacteria (e.g., penicillins, aminoglycosides).
• Bacteriostatic: inhibit bacterial growth, relying on host defenses to clear infection (e.g., tetracyclines, sulfonamides).

Major mechanisms of action:

• Inhibition of cell wall synthesis — Beta-lactams (penicillins, cephalosporins) bind transpeptidase (penicillin-binding proteins), preventing peptidoglycan cross-linking and causing cell lysis (effective mainly against growing bacteria).
• Inhibition of protein synthesis — Drugs bind bacterial ribosomes (30S or 50S subunits) and block translation (e.g., tetracyclines block tRNA binding to 30S; chloramphenicol inhibits peptidyl transferase on 50S; aminoglycosides cause mistranslation).
• Inhibition of nucleic acid synthesis — Fluoroquinolones inhibit DNA gyrase/topoisomerase; rifamycins inhibit RNA polymerase.
• Antimetabolite action — Sulfonamides and trimethoprim block folate synthesis (competitive inhibition), disrupting DNA/RNA synthesis.
• Disruption of cell membrane — Polymyxins interact with bacterial membranes, increasing permeability (mainly Gram-negatives).

Important structural feature: The beta-lactam ring (a four-membered cyclic amide) is the key reactive motif in penicillins and cephalosporins; it acylates the active site serine of transpeptidases, inactivating them. Beta-lactamases produced by resistant bacteria hydrolyze this ring, rendering the antibiotic inactive.

Resistance — causes and mechanisms:

• Enzymatic inactivation (e.g., beta-lactamase hydrolyzing beta-lactams).
• Alteration of target sites (e.g., altered penicillin-binding proteins in MRSA).
• Decreased permeability or increased efflux pumps (reduces intracellular concentration).
• Metabolic bypass (acquiring alternate pathways or enzymes).

Side effects and considerations: Allergic reactions (penicillin hypersensitivity), disruption of normal flora leading to superinfections (e.g., Clostridioides difficile), nephrotoxicity (aminoglycosides), hepatotoxicity, and drug interactions. Use antibiotics only when indicated and complete prescribed courses.

Therapeutic index and dosage: Antibiotics should have a high therapeutic index (ratio of toxic dose to effective dose). Clinical dosing considers pharmacokinetics (absorption, distribution, metabolism, excretion) and pharmacodynamics (time- or concentration-dependent killing).

Laboratory assessment: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determine susceptibility. Kirby–Bauer disk diffusion provides qualitative susceptibility (zone of inhibition).

Role in everyday life and public health: Antibiotics saved millions of lives but overuse/misuse has accelerated resistance. Antibiotic stewardship (appropriate prescription, correct dose/duration, avoiding antibiotics for viral infections) and development of new drugs are essential.

Fig 7 — Educational Diagram: Antiviral and Antitubercular Drugs (brief)

Overview: Antiviral drugs are agents that inhibit viral replication by targeting virus-specific stages (entry, uncoating, nucleic acid synthesis, assembly, release). Antitubercular drugs target Mycobacterium tuberculosis by disrupting cell wall synthesis, nucleic acid synthesis or protein synthesis. Treatment often uses combinations to prevent resistance.

Antiviral drugs — key modes of action

• Entry inhibitors: block virus attachment or fusion to host cells (e.g., enfuvirtide for HIV).
• Uncoating inhibitors: prevent release of viral genome (e.g., amantadine against influenza A).
• Nucleoside/nucleotide analogues: resemble natural nucleosides, are incorporated into viral DNA/RNA and terminate chain or inhibit polymerases (e.g., acyclovir, zidovudine/AZT).
• Reverse transcriptase inhibitors (RTIs): block HIV reverse transcriptase (e.g., AZT — nucleoside RTI; efavirenz — non-nucleoside RTI).
• Protease inhibitors: inhibit viral proteases needed to process polyproteins (HIV protease inhibitors).
• Neuraminidase inhibitors: block release of influenza virions (e.g., oseltamivir).

Antitubercular drugs — first-line agents and actions

• Isoniazid (INH): prodrug activated by mycobacterial catalase-peroxidase (KatG); inhibits mycolic acid synthesis (targets enzymes like InhA) — essential for cell wall.
• Rifampicin (rifampin): binds DNA-dependent RNA polymerase (β subunit), blocking RNA synthesis.
• Ethambutol: inhibits arabinosyl transferase, disrupting arabinogalactan synthesis in the mycobacterial cell wall.
• Pyrazinamide: converted to pyrazinoic acid inside bacteria; disrupts membrane energetics and transport, active in acidic conditions (e.g., within macrophages).
• Streptomycin: aminoglycoside that binds 30S ribosomal subunit, inhibiting protein synthesis.

Treatment principles & resistance: TB treatment uses combinations (e.g., R.I.P.E. regimen: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) for several months (usually 6 months for drug-susceptible TB) to prevent emergence of drug resistance. Viral therapy (especially HIV) uses combination antiretroviral therapy (cART). Resistance arises by mutations in target enzymes (e.g., rpoB mutations confer rifampicin resistance; mutations in reverse transcriptase or protease lead to antiviral resistance).

Side effects & monitoring (brief): Isoniazid — hepatotoxicity, peripheral neuropathy (prevent with pyridoxine B6); Rifampicin — hepatotoxicity, orange discoloration of body fluids, drug interactions; Pyrazinamide — hyperuricemia, hepatotoxicity; Ethambutol — optic neuritis (monitor vision); many antivirals can cause bone marrow suppression, hepatotoxicity or hypersensitivity.

Takeaway: Antiviral and antitubercular drugs act on specific biochemical targets of pathogens. Rational use (correct combinations, durations, adherence) is essential to cure infection and prevent resistance.

Fig 8 — Educational Diagram: Anesthetics

Definition: Anesthetics are drugs that produce loss of sensation (analgesia) or consciousness to permit painless surgical or diagnostic procedures. They are broadly classified into general anesthetics (produce reversible loss of consciousness) and local anesthetics (produce loss of sensation in a limited area without loss of consciousness).

Classification

• General anesthetics – inhalational (nitrous oxide, diethyl ether, chloroform, halothane, enflurane, isoflurane) and intravenous (thiopental, propofol, ketamine).
• Local anesthetics – esters (procaine, benzocaine, tetracaine) and amides (lidocaine, bupivacaine, prilocaine).

Mechanism of action (brief)

General anesthetics: multiple targets (potentiate inhibitory GABAergic transmission and/or inhibit excitatory NMDA receptors). Local anesthetics: block voltage-gated sodium (Na+) channels in nerve membranes, preventing rise of action potential and thus conduction of pain signals.

Structure–function highlights (local anesthetics)

• Typical local anesthetic architecture: aromatic (lipophilic) group — linker (ester or amide) — tertiary amine (hydrophilic). Lipophilicity helps membrane penetration; the tertiary amine becomes protonated and binds to the intracellular side of Na+ channel.
• Esters are hydrolysed quickly by plasma esterases (shorter duration) and can form para-aminobenzoic acid (PABA) derivatives (allergic reactions). Amides are metabolized in liver (longer duration).

Ideal properties of an anesthetic

• Rapid onset and controllable depth
• Minimal irritation and toxicity
• Non-flammable, stable, and non-reactive with surgical materials
• Good potency with acceptable therapeutic index

Key clinical points & side effects

• General anesthetics: respiratory depression, cardiovascular effects, post-operative nausea, malignant hyperthermia (rare, linked to some volatile agents and succinylcholine).
• Local anesthetics: CNS excitation followed by depression, cardiovascular toxicity at high doses, allergic reactions more common with ester type.

Metabolism

Esters: rapid hydrolysis by plasma esterases → short duration. Amides: hepatic metabolism (slower); adjust dosing in liver disease. Example hydrolysis reaction for esters: R–CO–O–R' + H2O → R–COOH + R'–OH (catalysed by esterases).

Important practical uses

• Dental work and minor surgery: lidocaine injections (local), topical benzocaine.
• Major surgeries: inhalational agents (halothane, isoflurane) often combined with IV agents.
• Epidural/spinal anesthesia: bupivacaine, ropivacaine.
• Emergency analgesia or sedation: nitrous oxide often used in combination with oxygen.

Note for students: remember the clinical distinctions (ester vs amide), the Na+ channel blockade mechanism for local anesthetics, and the relationships between physical properties (blood:gas partition coefficient, oil:gas partition coefficient) and onset/potency of inhalational agents.

Fig 9 — Educational Diagram: Tranquilizers, Sedatives and Hypnotics

Overview

Tranquilizers, sedatives and hypnotics are classes of central nervous system (CNS) depressant drugs used to reduce anxiety, produce calmness, induce sleep, or control seizures. Though related, the terms differ by clinical use:

• Tranquilizers (major vs minor): major tranquillisers = antipsychotics (used for psychosis); minor tranquillisers = anxiolytics (reduce anxiety) — benzodiazepines are typical minor tranquillisers.
• Sedatives: drugs that calm or reduce excitement without necessarily causing sleep.
• Hypnotics: drugs that induce and maintain sleep.

Most sedative–hypnotics act by enhancing the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) at the GABA-A receptor, increasing chloride ion (Cl–) influx into neurons, causing hyperpolarization and reduced neuronal excitability.

Main classes

• Barbiturates (e.g., phenobarbital, pentobarbital, thiopental): derived from barbituric acid. They increase the duration of GABA-A–activated Cl– channel opening and at high doses can directly activate the receptor. Used as sedatives, hypnotics, anticonvulsants and anaesthetics. Narrow therapeutic index; risk of respiratory depression and fatal overdose.
• Benzodiazepines (e.g., diazepam, lorazepam, alprazolam): they increase the frequency of GABA-A–activated Cl– channel opening. Used for anxiety, insomnia (short-term), muscle relaxation, seizure control and pre-operative sedation. Safer than barbiturates (wider therapeutic index) but cause dependence.
• Non‑benzodiazepine hypnotics (Z-drugs) (e.g., zolpidem, zopiclone): bind selectively to benzodiazepine site on certain GABA-A receptor subtypes; used mainly for insomnia with less muscle-relaxant and anticonvulsant action.
• Other agents: certain antihistamines (diphenhydramine) and older agents (methaqualone) have sedative/hypnotic properties but are less commonly used due to side effects or abuse potential.

Mechanism (conceptual)

GABA (endogenous inhibitory NT) binds GABA-A receptor → Cl– channel opens → neuronal hyperpolarization → decreased firing. Sedative–hypnotic drugs are positive allosteric modulators at GABA-A (increase frequency/duration of channel opening) or, in high doses (barbiturates), can directly gate the channel.

Therapeutic considerations & risks

• Barbiturates: effective but high risk of tolerance, dependence, drug interactions (induce hepatic enzymes), respiratory depression; narrow safety margin.
• Benzodiazepines: safer acutely, but cause tolerance, physical dependence and withdrawal; cognitive impairment and falls in elderly.
• Z‑drugs: lower risk of dependence than older drugs but still possible; may cause weird sleep‑related behaviours (sleep‑walking).
• All depressants can interact with alcohol and opioids causing additive CNS and respiratory depression.

Important points for CBSE Class 12

• Know representative drugs and their uses: phenobarbital (anticonvulsant, sedative), diazepam (anxiolytic, anticonvulsant, muscle relaxant), thiopental (short‑acting anaesthetic induction), zolpidem (insomnia).
• Understand general mechanism via GABA‑A receptor and difference in action between barbiturates and benzodiazepines.
• Be aware of side effects: dependence, tolerance, respiratory depression, interactions with other CNS depressants.

Fig 10 — Educational Diagram: Narcotics and Stimulants

Overview
In the context of Class 12 Chemistry (Chemistry in Everyday Life), "Narcotics and Stimulants" are two broad categories of drugs that affect the central nervous system (CNS) in different ways. Narcotics (also called depressants or opioids in common usage) reduce pain and produce sedation, while stimulants increase alertness, attention and energy.

Classification and Examples

• Narcotics/Opioids: Natural and synthetic substances that act mainly on opioid receptors (μ, κ, δ) to produce analgesia and euphoria. Examples: morphine, codeine, heroin (diacetylmorphine).
• Stimulants: Compounds that increase CNS activity by increasing neurotransmitter levels (e.g., dopamine, norepinephrine). Examples: cocaine, amphetamines, methamphetamine, caffeine, nicotine.

How they act (Mechanism of action — simple explanation)

• Narcotics/Opioids: Bind to opioid receptors in the brain and spinal cord → reduce perception of pain, produce sedation and euphoria. Repeated use leads to tolerance and physical dependence.
• Stimulants: Increase synaptic concentrations of monoamine neurotransmitters (dopamine, noradrenaline) by promoting release and/or blocking reuptake → increased alertness, elevated mood, elevated heart rate and blood pressure.

Effects, Risks and Medical Use

• Therapeutic uses: Morphine and codeine — strong and moderate analgesics respectively; certain amphetamines — treatment of ADHD and narcolepsy (under prescription); caffeine — mild stimulant used widely.
• Adverse effects: Narcotics — respiratory depression, constipation, sedation, risk of addiction; Stimulants — insomnia, anxiety, tachycardia, hypertension, risk of psychosis and addiction. Long-term abuse causes social, physical and mental harm.
• Tolerance and dependence: Both classes can cause physiological tolerance (higher dose required for same effect) and withdrawal symptoms on cessation.

Chemical perspective

• Narcotic opioids often contain multiple fused rings and polar functional groups (e.g., phenolic –OH in morphine); small structural changes (e.g., acetylation) can greatly change potency and pharmacokinetics (heroin is more lipid-soluble than morphine).
• Stimulants include diverse structures: alkaloids (cocaine, nicotine), xanthines (caffeine), and simple amines (amphetamine family) — structure influences ability to cross the blood–brain barrier and interact with transporters/receptors.

Societal and legal context

Many narcotics and stimulants are controlled substances — some are legal for medical use under prescription, others are illegal when used recreationally. Education, prevention and medical treatment (detoxification, behavioral therapy, substitution therapy) are used to manage abuse.

Important safety note

This summary is for educational purposes only. It does not provide instructions for synthesis, extraction, or illicit use of any controlled substances.

Fig 11 — Educational Diagram: Cardiovascular Drugs and Anticoagulants (overview)

Introduction: Cardiovascular drugs are medicines that act on the heart and blood vessels to treat conditions such as hypertension, angina, arrhythmias and heart failure. Anticoagulants prevent or treat blood clots (thrombi) by interfering with the blood coagulation cascade. Together these drugs reduce cardiovascular morbidity and mortality.

Main classes of cardiovascular drugs (summary)

• Nitrates (e.g., nitroglycerin): vasodilators that release nitric oxide (NO) causing venodilation → reduced preload and myocardial oxygen demand. Used in acute angina (sublingual tablets/sprays).
• Beta-blockers (e.g., propranolol, atenolol): antagonize β-adrenergic receptors → lower heart rate, contractility and blood pressure; useful in hypertension, angina, arrhythmias and post‑MI care.
• Calcium channel blockers (e.g., verapamil, amlodipine): block L-type Ca2+ channels in heart and vessels → vasodilation and reduced contractility (verapamil affects heart rate more; dihydropyridines like amlodipine mainly vasodilate).
• ACE inhibitors / ARBs (e.g., captopril, enalapril, losartan): inhibit angiotensin II formation or action → vasodilation, decreased aldosterone; used in hypertension and heart failure.
• Diuretics (e.g., hydrochlorothiazide, loop diuretics like furosemide): increase renal excretion of salt and water → reduce blood volume and BP.
• Cardiac glycosides (e.g., digoxin): inhibit Na+/K+-ATPase → increase intracellular Ca2+ in cardiomyocytes → positive inotropy; used in certain heart-failure and atrial fibrillation cases.
• Antiarrhythmics: many classes (Na+ channel blockers, β‑blockers, K+ channel blockers) used to restore/maintain normal rhythm.

Anticoagulants — overview and mechanisms

• Heparin (unfractionated heparin, UFH): a sulfated polysaccharide that potentiates antithrombin III → rapid inhibition of thrombin (factor IIa) and factor Xa. Administered IV or SC; monitored by aPTT.
• Low-molecular-weight heparins (LMWH) (e.g., enoxaparin): preferentially inhibit factor Xa, more predictable pharmacokinetics, often given SC without frequent monitoring.
• Vitamin K antagonists (warfarin): inhibit vitamin K epoxide reductase → reduce activation (γ-carboxylation) of clotting factors II, VII, IX and X and proteins C/S. Oral, slow onset, monitored by INR (prothrombin time). Interacts with foods and many drugs.
• Direct oral anticoagulants (DOACs or NOACs): direct thrombin inhibitors (e.g., dabigatran) or direct factor Xa inhibitors (e.g., rivaroxaban, apixaban) — predictable dosing, fewer interactions, no routine INR monitoring.
• Antiplatelet agents (aspirin, clopidogrel) are not classical anticoagulants but prevent arterial thrombosis by inhibiting platelet aggregation and are important in cardiovascular prevention.

Key clinical uses: hypertension, angina, acute coronary syndrome (antiplatelet + anticoagulant), heart failure (ACE inhibitors, beta-blockers, diuretics, digoxin in select cases), arrhythmias (beta-blockers, antiarrhythmics), prophylaxis/treatment of venous thromboembolism and stroke prevention in atrial fibrillation (anticoagulants).

Important monitoring and adverse effects

• Bleeding is the major adverse effect of all anticoagulants.
• Warfarin requires INR monitoring and has many drug–food interactions (vitamin K rich foods reduce effect).
• Heparin can cause heparin‑induced thrombocytopenia (HIT).
• Beta‑blockers can cause bradycardia, fatigue; nitrates can cause headache and hypotension; digoxin toxicity causes nausea, visual disturbances and arrhythmias.

Practical takeaways: choose therapy based on condition, speed of onset, route, monitoring needs and bleeding risk. For acute anticoagulation (e.g., perioperative, acute DVT/PE) heparin/LMWH are used; for long-term oral anticoagulation warfarin or DOACs are chosen based on patient profile.

Fig 12 — Educational Diagram: Antacids and Digestive Aids

Overview: Antacids are substances that neutralize excess gastric acid (HCl) in the stomach to relieve heartburn, acidity and indigestion. "Digestive aids" is a broader term that includes antacids and also drugs or supplements that reduce acid secretion (H2‑blockers, proton pump inhibitors) or supply digestive enzymes (e.g., pancreatin, lactase) to help digestion.

How antacids work: Antacids are basic compounds (carbonates, hydroxides, bicarbonates) that react with HCl in the stomach to form a salt and water (and sometimes CO₂). This raises gastric pH, giving rapid symptomatic relief. Because they act by chemical neutralization, their effect is fast but usually short‑lived.

Common antacid types and reactions:

• Systemic antacid (readily absorbed): sodium bicarbonate (NaHCO₃) — reacts fast but may produce CO₂ and systemic alkalosis on overuse:
  NaHCO₃ + HCl → NaCl + H₂O + CO₂
• Non‑systemic antacids (poorly absorbed):
• Calcium carbonate (CaCO₃): CaCO₃ + 2HCl → CaCl₂ + H₂O + CO₂
• Magnesium hydroxide (Mg(OH)₂): Mg(OH)₂ + 2HCl → MgCl₂ + 2H₂O
• Aluminium hydroxide (Al(OH)₃): Al(OH)₃ + 3HCl → AlCl₃ + 3H₂O
• Combinations (e.g., Mg(OH)₂ + Al(OH)₃) are common to balance side effects (Mg causes diarrhea, Al causes constipation).
• Anti‑foaming agents (simethicone) are added to some antacid preparations to reduce gas/bloating.

Other digestive aids:

• H₂-receptor antagonists (reduce acid secretion): e.g., famotidine, cimetidine. (These do not neutralize acid but decrease its production.)
• Proton pump inhibitors (PPIs) (block acid secretion at the parietal cell): e.g., omeprazole, lansoprazole — longer lasting, used for ulcers and reflux.
• Digestive enzyme supplements: pancreatin (mixture of amylase, lipase, protease) for pancreatic insufficiency; lactase for lactose intolerance.

Side effects & interactions:

• Sodium bicarbonate: rapid action but belching (CO₂) and risk of systemic alkalosis or sodium overload.
• Calcium carbonate: may cause belching, constipation and milk‑alkali syndrome if overused.
• Magnesium salts: can cause osmotic diarrhea and are contraindicated in renal failure.
• Aluminium salts: cause constipation and can bind dietary phosphate leading to hypophosphatemia on prolonged use.
• Antacids can alter gastric pH and interfere with absorption of other drugs (e.g., reduced absorption of tetracyclines, fluoroquinolones, iron). Recommended spacing: take antacids 1–2 hours apart from many oral drugs.

Practical points: Antacids are for symptomatic relief of mild, occasional acidity. For frequent or severe symptoms, acid‑reducing drugs (H₂ blockers or PPIs) and medical evaluation are indicated. Use enzyme supplements when specific enzyme deficiency or intolerance is diagnosed.

Fig 13 — Educational Diagram: Vitamins

What are vitamins? Vitamins are a group of organic compounds required in small amounts for normal metabolism, growth and maintenance of the body. They are essential nutrients because the body cannot synthesize adequate amounts (or any) of most of them, so they must be obtained from the diet.

Classification (based on solubility):

• Fat-soluble vitamins: A, D, E, K. They are soluble in fats and oils, stored in body fatty tissues and liver, and require dietary fats for absorption.
• Water-soluble vitamins: Vitamin C and the B-complex group (B1, B2, B3, B5, B6, B7, B9, B12). They dissolve in water, are not stored to any large extent (except B12), and excess amounts are excreted in urine.

Major functions and biochemical roles (selected):

• Vitamin A (retinol/retinal): vision (component of rhodopsin), growth and epithelial maintenance. Provitamin: beta-carotene.
• Vitamin D (calciferols): regulation of calcium and phosphate metabolism; promotes bone mineralization. Produced in skin from 7-dehydrocholesterol under UV light.
• Vitamin E (tocopherols): antioxidant protecting cell membranes from oxidative damage.
• Vitamin K (phylloquinone/menaquinone): required for gamma-carboxylation of glutamate residues in clotting factors (blood coagulation).
• Vitamin C (ascorbic acid): reducing agent, collagen synthesis (hydroxylation of proline/lysine), antioxidant, helps iron absorption.
• B-complex vitamins: act mainly as coenzymes/cofactors in metabolic pathways (e.g., B1 in carbohydrate metabolism as TPP; B2 in redox reactions as FAD/FMN; B3 as NAD+/NADP+; B6 in amino acid metabolism; B9 and B12 in one-carbon metabolism and nucleic acid synthesis).

Deficiency and diseases (key examples):

• Vitamin A deficiency: night blindness, xerophthalmia, increased infection risk.
• Vitamin D deficiency: rickets in children, osteomalacia in adults.
• Vitamin C deficiency: scurvy — bleeding gums, poor wound healing.
• Vitamin K deficiency: bleeding and hemorrhage due to impaired clotting.
• Vitamin B1 (thiamine) deficiency: beriberi (peripheral neuropathy, cardiac failure).
• Vitamin B3 (niacin) deficiency: pellagra — dermatitis, diarrhea, dementia.
• Vitamin B12 deficiency: megaloblastic anemia and neurological symptoms (pernicious anemia if due to intrinsic factor deficiency).

Toxicity (hypervitaminosis): Fat-soluble vitamins (especially A and D) can accumulate and cause toxicity at high doses (e.g., hypervitaminosis A — nausea, headache, liver abnormalities; hypervitaminosis D — hypercalcemia). Most water-soluble vitamins are less likely to reach toxic levels, though very high doses of some (e.g., B6) can cause adverse effects.

Chemical behaviour and important reactions (selected):

• Vitamin C is a good reducing agent; it is oxidized reversibly to dehydroascorbic acid. This underlies its role in collagen hydroxylation and antioxidant activity.
• Vitamin D synthesis: 7-dehydrocholesterol (in skin) --(UV light)--> previtamin D3 --(thermal isomerization)--> cholecalciferol (vitamin D3) --(liver & kidney hydroxylations)--> active 1,25-dihydroxycholecalciferol.
• Vitamin A: beta-carotene (a carotenoid) can be enzymatically cleaved to form retinal, which interconverts with retinol and participates in the visual cycle (retinal + opsin → rhodopsin).
• Many B vitamins form coenzymes: e.g., B1 → thiamine pyrophosphate (TPP), B2 → FAD/FMN, B3 → NAD+/NADP+, B6 → pyridoxal phosphate (PLP).

Practical notes: Many foods are fortified with vitamins (e.g., milk with vitamin D, cereals with B vitamins). A balanced diet of fruits, vegetables, dairy, meats, legumes and whole grains usually provides most required vitamins.

Fig 14 — Educational Diagram: Enzymes

Definition: Enzymes are biological catalysts, mostly globular proteins (some RNAs called ribozymes) that speed up biochemical reactions by lowering activation energy without being consumed.

Characteristics:

• Highly specific for substrates (substrate specificity) and reactions (reaction specificity).
• Active site: small region where substrate binds and reaction occurs.
• Function under mild physiological conditions (temperature, pH).
• Are not permanently altered during catalysis and act in small amounts.

Classification (EC classes):

• Oxidoreductases: oxidation–reduction reactions.
• Transferases: transfer of functional groups.
• Hydrolases: hydrolysis reactions (e.g., proteases, lipases).
• Lyases: addition/removal of groups to form double bonds.
• Isomerases: intramolecular rearrangements.
• Ligases: bond formation coupled to ATP hydrolysis.

Cofactors and Coenzymes: Some enzymes require nonprotein helpers. Cofactors are metal ions (Fe2+, Mg2+, Zn2+). Coenzymes are organic molecules like NAD+, FAD, CoA, PLP, TPP, biotin.

Mechanisms of substrate recognition:

• Lock-and-key model: complementary shapes of active site and substrate.
• Induced-fit model: enzyme changes conformation on substrate binding to achieve optimal fit and catalysis.

Factors affecting enzyme activity:

• Substrate concentration: rate increases with [S] until Vmax.
• Enzyme concentration: rate proportional to [E] when substrate in excess.
• Temperature: activity increases with temperature up to an optimum, then denaturation causes rapid fall.
• pH: each enzyme has an optimum pH; deviation alters ionization of active site and can denature the enzyme.
• Inhibitors: reversible (competitive, noncompetitive, uncompetitive) and irreversible inhibitors reduce activity.
• Allosteric effectors: activators or inhibitors bind at regulatory sites and change activity.

Enzyme kinetics (brief): The Michaelis–Menten model describes how initial reaction velocity v depends on substrate concentration [S]. It assumes formation of enzyme–substrate complex ES and steady state for ES.

Importance and applications in everyday life:

• Digestion: salivary amylase, gastric pepsin, pancreatic lipase and proteases break down food.
• Detergents: proteases, lipases and amylases remove protein, fat and starch stains.
• Food industry: lactase for lactose-free milk, pectinase for juice clarification, invertase in confectionery.
• Medicine: enzyme assays for diagnostics, enzyme inhibitors as drugs (e.g., ACE inhibitors), enzymes in drug design.
• Biotechnology: restriction enzymes, DNA polymerase in PCR, immobilized enzymes in reactors (glucose isomerase for high-fructose corn syrup).
• Environmental: biodegradation and wastewater treatment using enzymatic processes.

Stability and denaturation: Extreme pH or temperature, heavy metals, organic solvents, or detergents can denature enzymes by disrupting tertiary structure, causing loss of activity.

Fig 15 — Educational Diagram: Hormones (brief)

What are hormones? Hormones are chemical messengers secreted by endocrine glands into the blood. They travel to target cells/organs and regulate physiological processes such as growth, metabolism, reproduction and homeostasis.

Chemical nature & classification: Hormones belong to three main chemical classes:

• Peptide/protein hormones (e.g., insulin, growth hormone) — chains of amino acids; water soluble; act via cell-surface receptors and second messengers (cAMP, Ca2+).
• Steroid hormones (e.g., testosterone, estrogen, cortisol) — derived from cholesterol; lipid soluble; pass through cell membranes and bind intracellular receptors to regulate gene transcription.
• Amino-acid–derived hormones (e.g., adrenaline, thyroxine) — modified amino acids; mode of action depends on solubility (catecholamines use surface receptors; thyroid hormones act intracellularly).

Mechanism of action (brief): Peptide hormones bind to membrane receptors → activate second messenger cascades (e.g., adenylate cyclase → cAMP) → rapid cellular responses. Steroid and thyroid hormones cross the membrane → bind intracellular receptors → hormone–receptor complex modulates gene expression → slower but long-lasting effects.

Physiological & clinical significance: Hormones maintain homeostasis (e.g., insulin lowers blood glucose; glucagon raises it), control stress response (adrenaline, cortisol), regulate growth and reproduction (growth hormone, sex steroids), and are used as medicines — insulin for diabetes, synthetic corticosteroids as anti-inflammatory drugs, oral contraceptives (steroid analogues), levothyroxine for hypothyroidism.

Important concepts: negative feedback (common regulatory motif), pulsatile and circadian secretion (e.g., cortisol, melatonin), hormone transport (many steroids/thyroid hormones travel bound to carrier proteins), and endocrine disruptors (chemicals like bisphenol A can mimic hormones).

Fig 16 — Educational Diagram: Drug Dependence, Side Effects and Safety

Overview
Drugs are chemical substances used to prevent, diagnose or treat disease. While beneficial, many drugs can produce undesirable effects, and some can lead to dependence. Understanding types of dependence, side effects and principles of safe use (therapeutic index, dosing, interactions) is essential.

Drug Dependence
Drug dependence is a state in which a person requires continued use of a drug to function normally. It occurs in two main forms:

• Physical dependence: The body adapts to the drug; stopping causes physiological withdrawal symptoms (e.g., tremors, nausea). Example: opioid withdrawal after stopping morphine.
• Psychological dependence: Emotional or mental craving for the drug without severe physical withdrawal. Example: craving for nicotine or certain stimulants.

Tolerance
Tolerance is a reduction in response to a drug after repeated use so larger doses are needed for the same effect. Mechanisms include:

• Pharmacodynamic tolerance — receptor down‑regulation or desensitisation.
• Pharmacokinetic tolerance — enhanced metabolism (enzyme induction) lowering drug concentration.
• Behavioral tolerance — learned adaptation to drug effects.

Withdrawal
When a dependent person stops taking the drug, withdrawal symptoms (opposite of the drug's effects) occur until homeostasis is restored. Severity depends on drug class, dose and duration.

Side Effects and Adverse Drug Reactions (ADRs)
Side effects are unintended effects that occur at normal therapeutic doses. Adverse drug reactions are harmful or unpleasant reactions that may require discontinuation. Types include:

• Predictable (dose-related) — e.g., excessive bleeding with high doses of aspirin.
• Idiosyncratic (unpredictable) — uncommon reactions not related to dose, often genetic.
• Allergic / hypersensitivity — immune-mediated (e.g., penicillin allergy causing anaphylaxis).
• Teratogenic — causing fetal malformation (e.g., isotretinoin).
• Carcinogenic — long-term cancer risk with some agents.

Common real-life examples (brief):

• Morphine and other opioids: effective analgesics but cause dependence, respiratory depression and constipation.
• Benzodiazepines: anxiolytic/sedative; risk of tolerance, dependence and dangerous interaction with alcohol.
• Paracetamol (acetaminophen): safe at recommended doses but hepatotoxic in overdose via a toxic metabolite (NAPQI).
• Aspirin: analgesic/antipyretic; can cause gastric bleeding and in children is linked to Reye's syndrome.
• Penicillin: effective antibiotic but can cause severe allergic reactions in sensitive individuals.

Drug Safety Principles

• Use the minimum effective dose for the shortest necessary time.
• Beware of drug–drug interactions: additive, synergistic (potentiation), or antagonistic effects. Example: alcohol plus benzodiazepines = enhanced CNS depression.
• Monitor vulnerable populations: children, elderly, pregnant women, patients with liver/kidney disease.
• Report adverse reactions (pharmacovigilance) and follow prescribing information.

Key pharmacological safety concepts

• Therapeutic window — the range of doses/concentrations that produce therapeutic effect without unacceptable adverse effects.
• Therapeutic index (TI) — a numerical measure of drug safety (see formulas below).

Summary
Understanding drug dependence, side effects and safety helps ensure drugs are used effectively and with minimal harm. Rational prescribing, awareness of interactions, correct dosing and monitoring reduce risks of dependence and adverse effects.

Fig 17 — Educational Diagram: Public Health and Rational Use of Chemicals

Overview
Public health and rational use of chemicals deals with how chemicals are used to prevent disease, maintain hygiene, treat illness and protect the environment — while minimising harmful effects due to misuse, overuse or persistence.

Major areas

• Water purification and sanitation: Removal of suspended matter, microbial disinfection (chlorination, bleaching powder, chloramines), filtration and adsorption (activated carbon) to provide safe drinking water.
• Antiseptics, disinfectants and sterilisation: Antiseptics are used on living tissues (e.g., 70% ethanol, povidone-iodine), disinfectants on inanimate surfaces (e.g., sodium hypochlorite, phenols). Sterilisation (autoclaving, dry heat) kills all microbes.
• Drugs and antibiotics: Drugs for therapy include analgesics, antipyretics, antibiotics, antivirals, vaccines and more. Rational use means correct indication, dose, duration and avoiding self-medication and overuse to prevent resistance.
• Pesticides and insecticides: Organophosphates and organochlorines are effective but can be toxic and persistent (DDT) causing bioaccumulation and ecological harm; modern approaches favour integrated pest management (IPM) and safer alternatives (biopesticides, neem-based preparations).
• Food additives, preservatives and adulteration: Preservatives (benzoates, sorbates, sulphites) prevent spoilage. Adulteration (adding cheaper or harmful substances) is a public health risk and must be detected and prevented.
• Toxicity, bioaccumulation and antidotes: Understanding acute and chronic toxicity (LD50), biomagnification in food chains, and treatments/chelators for heavy metal poisoning are part of safe chemical use.

Principles of rational use of chemicals

• Use the minimum effective quantity and the least persistent/toxic chemical possible.
• Prefer targeted, specific agents (narrow-spectrum where possible) to reduce collateral damage (e.g., narrow-spectrum antibiotics).
• Follow recommended doses, durations and safety procedures (PPE, disposal protocols).
• Apply Integrated Pest Management (IPM): cultural, biological controls first; chemical controls only when necessary.
• Monitor residues in food, water and the environment; regulate and phase out persistent toxic chemicals.

Important public-health applications — short notes

• Chlorination of water: Chlorine or bleaching powder produces hypochlorous acid (HOCl), a powerful disinfectant that inactivates bacteria and viruses. Proper dosing leaves a safe residual to prevent recontamination.
• Antibiotics & resistance: Incomplete courses and indiscriminate use select for resistant strains (e.g., MRSA). Rational prescribing, surveillance and new drug development are needed.
• Pesticide hazards: Persistent organochlorines (e.g., DDT) biomagnify in food chains, causing ecological harm (eggshell thinning in birds) and human health risks.
• Vaccination: Vaccines (live-attenuated, inactivated, toxoids, subunit) are chemical/biochemical tools that produce immunity and prevent outbreaks.

Policies & practices that protect public health

• Regulation of drug sale and prescription; banning/restricting hazardous pesticides and additives.
• Public education on hygiene, safe handling and correct use of medicines and chemicals.
• Adoption of greener alternatives and waste-management systems to prevent environmental contamination.

Summary: The goal is effective disease control and health protection while minimising environmental and human harm — achieved by correct choice, dose, timing, monitoring and safer alternatives.